Amoeba Networks welcomes RenBio
Jul 19, 2021
Amoeba is thrilled to welcome our new partner, @RenBio, a privately-held, preclinical biotechnology company developing novel, best-in-class antiviral antibody therapeutics and a next-generation antibody delivery platform founded on the principle that the remarkable medical benefits of antibody therapeutics should be available to everyone.
Read more